Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
Kaegi
E
E
National Cancer Institute of Canada, Toronto, Ont.
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D000529:Complementary Therapies; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D014784:Mistletoe / Q000009:adverse effects / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008517:Phytotherapy; D010936:Plant Extracts / Q000009:adverse effects / Q000627:therapeutic use*; D010940:Plant Proteins; D010946:Plants, Medicinal; D012449:Safety; D016896:Treatment Outcome
D000972:Antineoplastic Agents, Phytogenic; D010936:Plant Extracts; D010940:Plant Proteins; C077177:viscum album peptide